Evidence map›Paper›PMID 25863341›Full record

ReviewCurrent opinion in genetics & development2015

The lure of zebrafish in liver research: regulation of hepatic growth in development and regeneration.

Andrew G Cox, Wolfram Goessling

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in genetics & development, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 53 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Methods to Study Liver Disease Using Zebrafish Larvae.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  7. Evaluation of the hepatotoxicity ofFrontiers in pharmacology · 2024
    Article
  8. Review
  9. Article
  10. Zebrafish-An Optimal Model in Experimental Oncology.Molecules (Basel, Switzerland) · 2022
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Andrew G CoxBrigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
Wolfram GoesslingBrigham and Women's Hospital, Harvard Medical School, Boston, MA, United States; Dana-Farber Cancer Institute, Boston, MA, United States; Harvard Stem Cell Institute, Cambridge, MA, United States; Broad Institute of MIT and Harvard, Cambridge, MA, United States. Electronic address: wgoessling@partners.org.
Harvard University · US

Funding

Estrogen Regulation of Hepatic GrowthR01DK090311 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI GOESSLING, WOLFRAM · 2011 to 2020
$4.9M
Mutant mapping and identification in zebrafish by next generation sequencingR01DK095721 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI BEIER, DAVID R., GOESSLING, WOLFRAM · 2012 to 2016
$1.9M
NIDDK NIH HHS R01 DK090311NIDDK NIH HHS R01DK090311NIDDK NIH HHS R01 DK095721NIDDK NIH HHS R01DK095721
6 · The paper itself

Abstract

The liver is an essential organ that plays a pivotal role in metabolism, digestion and nutrient storage. Major efforts have been made to develop zebrafish (Danio rerio) as a model system to study the pathways regulating hepatic growth during liver development and regeneration. Zebrafish offer unique advantages over other vertebrates including in vivo imaging at cellular resolution and the capacity for large-scale chemical and genetic screens. Here, we review the cellular and molecular mechanisms that regulate hepatic growth during liver development in zebrafish. We also highlight emerging evidence that developmental pathways are reactivated following liver injury to facilitate regeneration. Finally, we discuss how zebrafish have transformed drug discovery efforts and enabled the identification of drugs that stimulate hepatic growth and provide hepatoprotection in pre-clinical models of liver injury, with the ultimate goal of identifying novel therapeutic approaches to treat liver disease.

Indexed as

Models, AnimalZebrafishAnimalsDevelopmental BiologyDrug DiscoveryLiverRegenerationSignal Transduction

Identifiers

PMID25863341
PMCPMC4780866
OpenAlexW2063869612

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.